Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
British Journal of Haematology|September 30, 2024
The power and perils of large language models in haematologyJacob Glass, Olivier ElementoLeukemia Research|May 14, 2023
Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemiaEvan Atchley, Taylor M Weis, Andriy Derkach, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2026
Second Primary Malignancy Risk in Patients with Multiple Myeloma Receiving CAR T-Cell Therapy or Other Systemic Anticancer Treatments: A Real-World Comparative StudyAttaya Suvannasankha, Mengying Li, Omonefe Omofuma, et al.Biorxiv : the Preprint Server for Biology|February 6, 2026
TET2 and TP53 Mutations Cooperatively Modulate the Response to Inflammation to Promote Leukemic TransformationPablo Sánchez Vela, Brianna Kelly, Claudia Brady, et al.Blood|January 27, 2009
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid featuresMaria E Figueroa, Bas J Wouters, Lucy Skrabanek, et al.PLOS Digital Health|February 22, 2023
Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2)William A Wood, Deepika Dilip, Andriy Derkach, et al.Blood|August 2, 2018
Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesisElodie Pronier, Robert L Bowman, Jihae Ahn, et al.Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Acute myeloid leukemia with mixed phenotype is characterized by RUNX1 mutations, stemness features and limited lineage plasticityPallavi Galera, Deepika Dilip, Andriy Derkach, et al.Cancer Discovery|February 15, 2017
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid LeukemiaAlan H Shih, Cem Meydan, Kaitlyn Shank, et al.Blood|January 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotypePallavi Galera, Deepika Dilip, Andriy Derkach, et al.Pageof 2